Internationally-respected Canadian researcher and founding CIHR
president to fill prestigious advanced research leadership post
TORONTO, Jan. 11, 2012 /CNW/ - On behalf of the Board of the Canadian
Institute for Advanced Research, David Dodge announced today the
appointment of Dr. Alan Bernstein as the Institute's new President and
CEO commencing May 1, 2012.
"Alan is a visionary leader who has a wealth of experience guiding
pioneering enterprises that conduct leading-edge research and promote
interdisciplinary collaboration, just like CIFAR," said Chair David
Dodge. "It's great to have him back in Canada."
Last year, CEO Chaviva Hošek informed the Board that she would be
retiring and a rigorous international search for her successor began.
Most recently, Dr. Bernstein was executive director of the Global HIV
Vaccine Enterprise in New York, an international alliance of
researchers and funders charged with accelerating the search for an HIV
vaccine. From 2000 to 2007, Dr. Bernstein served as the inaugural
president of the Canadian Institutes of Health Research, Canada's
federal agency for the support of health research, where he led the
transformation of health research in Canada.
"I have long admired CIFAR's focus on identifying and supporting
research that drives change and has the potential to improve human
health, the environment, societies, technology and our understanding of
the universe," said Alan Bernstein. "For the past 30 years, CIFAR has
been one of Canada's leading global research assets. I am honoured to
be selected to succeed Chaviva Hošek as its next president and CEO."
David Dodge also recognized the extraordinary tenure of Chaviva Hošek
who continues as CEO until April 30, 2012. "Under Chaviva's leadership
over the last eleven years, the Institute has developed as Canada's
premier centre for advanced research, linking top Canadian researchers
to each other and to the world's best," said David Dodge.
"Working with CIFAR's board, researchers and supporters has been one of
the most creative and rewarding experiences of my career," said Chaviva
Hošek. "I am very proud of CIFAR's leadership in many promising areas
including the effects of early experience on the brain and biological
development and the role of institutions and groups in social
resilience and economic growth."
The Institute will be celebrating Dr. Hošek's leadership and CIFAR's 30th anniversary at a special event on June 12, 2012.
After receiving his PhD from the University of Toronto, and following
postdoctoral work at the Imperial Cancer Research Fund in London, Dr.
Bernstein joined the Ontario Cancer Institute. In 1985, he joined the
Samuel Lunenfeld Research Institute, was named its Associate Director
in 1988 and served as its Director of Research from 1994 to 2000 when
the government of Canada appointed him CIHR's first president. Dr.
Bernstein has authored over 225 scientific publications and has made
internationally recognized contributions to the study of stem cells,
the formation of blood cells (hematopoiesis) and cancer. He chairs or
is a member of advisory and review boards in Canada, the U.S., the
U.K., Italy and Australia. Dr. Bernstein has received numerous awards
and honourary degrees for his contributions to science, including the
2008 Gairdner Wightman Award. He is a Senior Research Fellow of Massey
College and, in 2002, was made an Officer of the Order of Canada.
CIFAR is a Canadian non-profit research institute that has been changing
the world of research and building Canada's research leadership for 30
years. Today, our researchers are working on big questions with the
potential to improve human health and the environment, transform
technology, build strong societies, understand human culture and chart
the universe. Nearly 400 researchers in 16 countries participate in our
long-term, multidisciplinary and collaborative advanced research teams.
CIFAR is supported by exceptional individuals, foundations,
corporations, the Government of Canada and the provincial governments
of Alberta, British Columbia and Ontario.
Image with caption: "CIFAR announces Dr. Alan Bernstein, O.C. as new President and CEO (CNW Group/Canadian Institute for Advanced Research)". Image available at: http://photos.newswire.ca/images/download/20120111_C3195_PHOTO_EN_8817.jpg
SOURCE Canadian Institute for Advanced Research
For further information: